search
Back to results

Sensory Stimulation Effect on Movement Speed in Patients With Parkinson Disease

Primary Purpose

Parkinson Disease

Status
Completed
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Aponeurotic stimulation (the diacutaneous fibrolysis method)
Placebo stimulation
Sponsored by
Université Libre de Bruxelles
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Parkinson Disease focused on measuring Parkinson Disease, sensory stimulation, Bradykinesia

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Clinical diagnosis of Parkinson Disease

Exclusion Criteria:

  • Patients with a limitation in the shoulder range of motion necessary to perform pointing movements

Sites / Locations

  • ULB-FSM Laboratory of neurophysiology and movement biomechanics

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Aponeurotic stimulation group

Placebo stimulation group

Arm Description

The stimulation consisted of manipulating, with a hook (the diacutaneous fibrolysis method), the aponeurotic tissues enrobing the heads of the trunk and upper limb muscles.

Placebo stimulation (PS) consisted of manipulating the skin along the same paths over the trunk, shoulder and arm muscles that were the targets for treatment in the Aponeurotic stimulation group.

Outcomes

Primary Outcome Measures

3D kinematic movement parameters and upper limb muscles electromyographic activation

Secondary Outcome Measures

Unified Parkinson's Disease Rating Scale (UPDRS)

Full Information

First Posted
February 23, 2012
Last Updated
March 5, 2012
Sponsor
Université Libre de Bruxelles
Collaborators
Fonds National de la Recherche Scientifique, Belgium: Belgian Federal Science Policy Office (BELSPO)
search

1. Study Identification

Unique Protocol Identification Number
NCT01544738
Brief Title
Sensory Stimulation Effect on Movement Speed in Patients With Parkinson Disease
Official Title
Aponeurotic Stimulation Effect on Parkinson Bradykinesia
Study Type
Interventional

2. Study Status

Record Verification Date
February 2012
Overall Recruitment Status
Completed
Study Start Date
November 2008 (undefined)
Primary Completion Date
May 2009 (Actual)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Université Libre de Bruxelles
Collaborators
Fonds National de la Recherche Scientifique, Belgium: Belgian Federal Science Policy Office (BELSPO)

4. Oversight

5. Study Description

Brief Summary
Movement slowness (bradykinesia) is one of the main motor symptoms in Parkinson Disease (PD). Several studies have shown that patients with PD exhibit slowness because they are unable to modulate, in an optimal way, the velocity of voluntary motor acts not induced by external stimulation. Indeed, these patients have difficulties to integrate multi-sensorial information, mainly proprioception. The investigators investigated changes in shoulder velocity during pointing movements by patients with PD after stimulation of soft tissues (aponeurosis) of upper limb muscles. The stimulation consisted of manipulating, with a hook (the diacutaneous fibrolysis method), the aponeurotic tissues enrobing the heads of the upper limb muscles. This technique has previously been shown to decrease passive tension and the tendon reflex response of the manipulated muscle group. The investigators hypothesis is that aponeurotic manipulation of shoulder muscles therefore creates a modification in the proprioceptive information, which in return temporarily decreases the bradykinesia of shoulder movements.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson Disease
Keywords
Parkinson Disease, sensory stimulation, Bradykinesia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
11 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Aponeurotic stimulation group
Arm Type
Experimental
Arm Description
The stimulation consisted of manipulating, with a hook (the diacutaneous fibrolysis method), the aponeurotic tissues enrobing the heads of the trunk and upper limb muscles.
Arm Title
Placebo stimulation group
Arm Type
Active Comparator
Arm Description
Placebo stimulation (PS) consisted of manipulating the skin along the same paths over the trunk, shoulder and arm muscles that were the targets for treatment in the Aponeurotic stimulation group.
Intervention Type
Other
Intervention Name(s)
Aponeurotic stimulation (the diacutaneous fibrolysis method)
Intervention Description
Treatment consisted of manipulating, with a hook, the aponeurotic tissues enrobing the heads of the upper-limb muscles. The manipulation consisted of back and forth mobilization, applied perpendicularly to the axis of the muscular fibers. The mobilization is performed with both hands; the therapist's non-dominant hand performs a manual mobilization whereas the dominant hand follows the movement with the hook. The hook allows the therapist to be very precise about the location of the tissues that are stretched. This stretch is realized at the level of the aponeurotic fibers presenting the greatest resistance to perpendicular movement. The shape of the hook is chosen to avoid discomfort or pain during manipulation. To spread the pressure exerted by the spatula on a very local point, it is important to fill completely the curved part of the hook with the adjacent soft tissues. We manipulated muscle from the proximal insertion towards the distal, giving special attention to the tendons.
Intervention Type
Other
Intervention Name(s)
Placebo stimulation
Intervention Description
Placebo stimulation (PS) consisted of manipulating the skin along the same paths over the trunk, shoulder and arm muscles that were the targets for treatment in the AS group
Primary Outcome Measure Information:
Title
3D kinematic movement parameters and upper limb muscles electromyographic activation
Time Frame
Participants will be followed for the duration of the clinical test (2 weeks)
Secondary Outcome Measure Information:
Title
Unified Parkinson's Disease Rating Scale (UPDRS)
Time Frame
Participants will be followed for the duration of the clinical test (2 weeks)

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of Parkinson Disease Exclusion Criteria: Patients with a limitation in the shoulder range of motion necessary to perform pointing movements
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ana Bengoetxea, PhD
Organizational Affiliation
Université Libre de Bruxelles
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Françoise Leurs, PhD Student
Organizational Affiliation
Université Libre de Bruxelles
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Leslie Rigal, Master Student
Organizational Affiliation
Université Libre de Bruxelles
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Guy Cheron, PhD
Organizational Affiliation
Université Libre de Bruxelles
Official's Role
Study Director
Facility Information:
Facility Name
ULB-FSM Laboratory of neurophysiology and movement biomechanics
City
Brussels
ZIP/Postal Code
1070
Country
Belgium

12. IPD Sharing Statement

Learn more about this trial

Sensory Stimulation Effect on Movement Speed in Patients With Parkinson Disease

We'll reach out to this number within 24 hrs